Dughayli Mohamad, DeFatta Jason, Dashtaei Ayda, Peace Amber, Baidoun Fadi, Olson Gregory
Henry Ford Wyandotte Hospital.
Spartan Med Res J. 2019 Jul 1;4(1):9061. doi: 10.51894/001c.9061.
The aim of this study is to evaluate the relationship between Breast Imaging Reporting and Data System and surgical biopsies that may increase effectiveness of wire-guided percutaneous localizations for non-palpable breast lesions.
A retrospective review of a sample of 149 patients who underwent wire-guided localization with wide local excision for non-palpable breast lesions at the authors' institution between January 2013 and April 2016. After IRB approval, sample patients' records were reviewed and data were collected concerning their radiological, histological and surgical characteristics.
One (0.67%) complication occurred related to wire migration. There were nine (6.04%) recorded cases of seroma and three (2.01%) cases of hematoma. Breast Imaging Reporting and Data System (BI-RADS) Category 4 was found to have a positive predictive value of 28.4% for breast cancer. Under Category 4 subcategorization 4A, 4B, and 4C, the number of positive lesions were two (6.89%), three (10.34%) and five (17.24%), respectively. Forty (78.43%) of the 51 patients with cancer had negative (i.e., non-cancerous) margins compared to 11 (21.57%) cases that had positive margins after the first procedure.
The BI-RADS Category 4 encompasses the majority of lesions, with approximately 70% of such biopsies lesions later found to be benign. A subcategorization of BI-RADS 4 needs further clarification in distinguishing benign vs malignant imaging characteristics. Future retrospective studies designed to identify benign vs. malignant lesions, confirmed by validating prospective studies, will better clarify a new subcategorization of BI-RADS Category 4, thus allowing surgeons and radiologists to make the best surgical recommendations for their patients.
本研究旨在评估乳腺影像报告和数据系统(Breast Imaging Reporting and Data System,BI-RADS)与手术活检之间的关系,这可能会提高用于不可触及乳腺病变的导丝引导下经皮定位的有效性。
对2013年1月至2016年4月期间在作者所在机构接受导丝引导下定位并广泛切除不可触及乳腺病变的149例患者样本进行回顾性研究。经机构审查委员会(IRB)批准后,查阅样本患者的记录,并收集有关其放射学、组织学和手术特征的数据。
发生了1例(0.67%)与导丝移位相关的并发症。记录到9例(6.04%)血清肿病例和3例(2.01%)血肿病例。发现BI-RADS 4类对乳腺癌的阳性预测值为28.4%。在4A、4B和4C这4类的亚分类中,阳性病变数量分别为2例(6.89%)、3例(10.34%)和5例(17.24%)。51例癌症患者中有40例(78.43%)切缘阴性(即非癌性),相比之下,首次手术后有11例(21.57%)切缘阳性。
BI-RADS 类别4涵盖了大多数病变,其中约70% 的此类活检病变后来被发现为良性。BI-RADS 4的亚分类在区分良性与恶性影像特征方面需要进一步明确。未来旨在识别良性与恶性病变的回顾性研究,通过前瞻性研究进行验证,将更好地明确BI-RADS 4类的新亚分类,从而使外科医生和放射科医生能够为患者做出最佳的手术建议。